Scientists increase potency of HIV-1 antibody, identify new ways to develop vaccines news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Madan, a postdoctoral researcher in the DeKosky lab at the University of Kansas School of Pharmacy, headed research into potential of the vFP16.02 antibody view more
Credit: Matheus Oliveira de Souza
LAWRENCE Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS. AIDS vaccine development has been a decades-long challenge partly because our immune systems have difficulty recognizing all the diverse variants of the rapidly mutating HIV virus, which is the cause of AIDS, said Brandon DeKosky, assistant professor of pharmaceutical chemistry and chemical & petroleum engineering at the University of Kansas.
Thu, 03/11/2021
LAWRENCE Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.
“AIDS vaccine development has been a decades-long challenge partly because our immune systems have difficulty recognizing all the diverse variants of the rapidly mutating HIV virus, which is the cause of AIDS,” said Brandon DeKosky, assistant professor of pharmaceutical chemistry and chemical & petroleum engineering at the University of Kansas.
In the past five years, tremendous progress has been made in identifying better vaccine methods to protect against many different HIV-1 variants. One important step was when scientists at the National Institute of Allergy and Infectious Disease’s Vaccine Research Center discovered a promising antibody called vFP16.02. Antibodies are proteins the immune system deploys to target and destroy pathogens and viruses and scientists at the NIH determ
Demand is strong, next few months growth momentum will be there, rural cash flows are strong and beyond June it will depend on how monsoon pans out : Bharat Madan, Group CFO, Escorts
Eden Roc
Photo courtesy of JLL
Brokers with JLL Capital Markets in San Diego have arranged a $17.5 million loan for the purchase of a Hayward manufactured home community.
The JLL Capital Markets team representing Hometown America in securing the 10-year fixed-rate Fannie Mae loan for the acquisition of the 21-acre community of Eden Roc was led by Managing Director Zach Koucos and Analyst Bharat Madan.
With 200 home sites, Eden Roc is fully occupied.
Amenities include a clubhouse, fitness center, recreation area, pool, spa, sauna, and children’s playground.
The loan will be serviced by JLL Real Estate Capital, LLC.
“Eden Roc is a great addition to Hometown’s portfolio and fits very well within our investment strategy of acquiring high-quality communities in target markets such as California,” said Matt Sears, Vice President of Hometown America.